Kura Oncology Stock Price on October 31, 2024
| KURA Stock | USD 11.17 0.42 3.91% |
Below is the normalized historical share price chart for Kura Oncology extending back to September 16, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kura Oncology stands at 11.17, as last reported on the 29th of November, with the highest price reaching 11.44 and the lowest price hitting 10.71 during the day.
If you're considering investing in Kura Stock, it is important to understand the factors that can impact its price. Kura Oncology has Sharpe Ratio of -0.15, which conveys that the firm had a -0.15% return per unit of risk over the last 3 months. Kura Oncology exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kura Oncology's Risk Adjusted Performance of (0.10), standard deviation of 5.17, and Mean Deviation of 2.39 to check out the risk estimate we provide.
At present, Kura Oncology's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 471.4 M, whereas Common Stock is forecasted to decline to 6,669. . At present, Kura Oncology's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 2.78, whereas Price Earnings Ratio is forecasted to decline to (7.24). Kura Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of September 2015 | 200 Day MA 19.7959 | 50 Day MA 17.31 | Beta 0.857 |
Kura |
Sharpe Ratio = -0.1459
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KURA |
Estimated Market Risk
| 5.25 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.77 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kura Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kura Oncology by adding Kura Oncology to a well-diversified portfolio.
Price Book 2.0497 | Book Value 5.451 | Enterprise Value 430 M | Enterprise Value Ebitda (2.48) | Shares Float 50.2 M |
Related Headline
Monte Rosa Headline on 31st of October 2024
Will Monte Rosa continue to dip in December by Macroaxis
Monte Rosa Therapeutics has $46.04 million in liabilities and a Debt to Equity (D/E) ratio of 0.16, indicating limited use of borrowing. With a current ratio of 19.71, the company is well-positioned to meet its financial obligations. When evaluating Monte Rosa's debt, it's important to consider its cash and equity positions. The company has a performance score of 11 out of 100 and a Beta of 5.01, suggesting high market risk. This means it could outperform in a rising market but may underperform if the market declines. To assess potential returns, consider using metrics like the Sortino ratio, skewness, period momentum indicator, and the relationship between potential upside and rate of daily change.
Key Discoveries
Monte Rosa Therapeutics' stock exhibits significant volatility, as highlighted by its Coefficient of Variation of 771.99, suggesting that price swings are substantial and could lead to unpredictable movements. With a Maximum Drawdown of 95.03, the stock has experienced severe declines, indicating that while a rebound is possible, investors should brace for potential further declines in December.Kura Oncology Valuation on October 31, 2024
It is possible to determine the worth of Kura Oncology on a given historical date. On October 31, 2024 Kura was worth 16.84 at the beginning of the trading date compared to the closed value of 16.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kura Oncology stock. Still, in general, we apply an absolute valuation method to find Kura Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kura Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kura Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 17.22 | 17.58 | 16.89 | 16.97 | 807,212 | |
10/31/2024 | 16.84 | 16.91 | 16.50 | 16.72 | 538,052 |
| 16.73 | 17.23 | 16.62 | 16.88 | 355,553 |
| Backtest Kura Oncology | | | Kura Oncology History | | | Kura Oncology Valuation | Previous | Next |
Kura Oncology Trading Date Momentum on October 31, 2024
| On November 01 2024 Kura Oncology was traded for 16.88 at the closing time. The top price for the day was 17.23 and the lowest listed price was 16.62 . The trading volume for the day was 355.6 K. The trading history from November 1, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 0.96% . The trading delta at closing time against the current closing price is 7.00% . |
Kura Oncology Fundamentals Correlations and Trends
By evaluating Kura Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kura Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kura financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kura Oncology Stock history
Kura Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kura is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kura Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kura Oncology stock prices may prove useful in developing a viable investing in Kura Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 73.2 M | 76.9 M | |
| Net Loss | -122.3 M | -116.1 M |
Kura Oncology Quarterly Net Working Capital |
|
Kura Oncology Stock Technical Analysis
Kura Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Kura Oncology Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Kura Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kura Oncology November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Kura Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kura Oncology shares will generate the highest return on investment. By undertsting and applying Kura Oncology stock market strength indicators, traders can identify Kura Oncology entry and exit signals to maximize returns
Kura Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kura Oncology's price direction in advance. Along with the technical and fundamental analysis of Kura Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kura to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.76) | |||
| Total Risk Alpha | (1.52) | |||
| Treynor Ratio | (5.44) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Kura Stock analysis
When running Kura Oncology's price analysis, check to measure Kura Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kura Oncology is operating at the current time. Most of Kura Oncology's value examination focuses on studying past and present price action to predict the probability of Kura Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kura Oncology's price. Additionally, you may evaluate how the addition of Kura Oncology to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |